Stay updated on PD-1 Inhibitor Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PD-1 Inhibitor Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-1 Inhibitor Combo in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No significant differences in the core content of the Study Details page between the two screenshots; the study title, status, enrollment, and locations appear the same, with any differences likely cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T09:51:45.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    - Added a government-operational-status notice and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T14:22:38.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version tag updated from v3.0.2 to v3.1.0; page now reflects the newer revision.
    Difference
    0.1%
    Check dated 2025-09-28T09:43:33.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 (replacing v3.0.1); 'Back to Top' element removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:13:27.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T21:08:54.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility names and locations, particularly in Moldova, Russia, Turkey, and Ukraine, while removing previous references to countries and cities in a more generic format.
    Difference
    5%
    Check dated 2025-08-30T15:37:39.000Z thumbnail image

Stay in the know with updates to PD-1 Inhibitor Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibitor Combo in NSCLC Clinical Trial page.